SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2024, between Celularity Inc., a Delaware corporation (the “Company”), and Dragasac Limited, a company incorporated in the Isle of Man (the “Purchaser”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations
This Agreement is made pursuant to the Second Amended and Restated Loan Agreement, dated as of the date hereof, between the Company and Holder (the “Loan Agreement”).
SECOND AMENDED AND RESTATED LOAN agreementLoan Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations • Delaware
This Second Amended and Restated Loan Agreement, dated as of January 12, 2024 (this “Agreement”), is by and among Celularity Inc., a Delaware corporation, and Celularity LLC, a Delaware limited liability company (each, individually, and, collectively, as the context may require, the “Borrower”), and Resorts World Inc Pte Ltd, a company incorporated in Singapore (the “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).
CELULARITY INC. SUPPORT AGREEMENTSupport Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations • Delaware
THIS SUPPORT AGREEMENT (this “Agreement”), dated as of January 16, 2024 is made by and among Celularity Inc., a Delaware corporation (“Celularity”), Resorts World Inc Pte Ltd, a company incorporated in Singapore (“RWI”), and the undersigned holders (each a “Stockholder”) of shares of capital stock (the “Shares”) of Celularity.
